Jugulo-tympanic paragangliomas are the most common primary neoplasm of the middle ear, but little is still known about the histological features differentiating the benign and malignant forms. We investigated, with an immunohistochemical procedure, the expression of neurotrophins with their receptors, in fifteen samples of paragangliomas, and MIB-l in order to consider them as prognostic factors of malignancy. We observed a general positivity for NGF -TrKA -NT4 -TrKC in the cytoplasm, and a strong expression for BDNF in the extracellular space. MIB-l was moderate in the nucleus of neoplastic cells, weak in the cytoplasm and totally absent in the extracellular space. The comparison between the clinical recurrences and the rate of cytoplasmatic neurotrophins showed strong lmmunereactlvity in recurrent patients. It should be emphasized that 2 of the 3 recurrences had a wider distribution of the neutrophins, leading to hypothesize the involvement of these substances in the cell proliferation of glomus tumors. Malignant forms of these rare glomus tumors cannot be clearly identified using MIB-l as a prognostic marker, although we can affirm that neurotrophins and their receptors can be considered as a panel of potential diagnostic markers to monitor the development of such malignancies. Although the small number of patients does not allow definitive conclusions to be made, our findings showed a possible trend towards significance which requires a more powerful study to evaluate this further.
levels of clinical aggressiveness with more surgical difficulties and variable patterns of recurrence. Since little is known about the pathological and histological differentiation among the benign and malignant forms of this tumor (malignancy is very rare), we decided to establish a panel of molecular factors, capable of better describing and clarifying this characterization. Therefore, as Yamamoto did previously (12) , we investigated the expression of neurotrophins and their relative receptors in samples of benign jugulotympanic tumors and in normal and neoplastic non-neural tissues (19) , to identify any direct involvement of these growth factors in the development of these neoplasms. In our surgical series, we selected intradural jugulotympanic tumors in order to analyse the clinical aggressiveness of these lesions comparing the proliferation rate of neutrophins expression and the incidence of recurrence. Neurotrophins (NTs), also known as neurotrophic factors (including NGF, BDNF, NT-3, NT-4) are involved in the modulation of adult central nervous system functions and organization, as well as in the neural control of different activities related to vegetative innervation of several organs (13) (14) (15) (16) (17) . We also included the analysis of MIB-l (ki-67 antigen) expression to define its possible role as a malignancy marker. Although many pathologists include an assessment of MIB-l labeling in diagnostic profile of paragangliomas, there is currently no prospect of a standardization, and reporting a Ki-67 index still remains optional (18) . Since we have previously described the role of MIB-l as a prognostic factor in other neoplasms (19) , we decided to investigate this factor, supporting the results shown by Rodriguez, who first described (using immunohistochemical techniques) the presence and the localization of MIB-l in these tumors (8) .
MATERIALSAND METHODS

Ethical considerations
Surgical samples of benign intradural jugulotympanic tumors were removed during resection operations from 10 different patients, together with 5 autoptic specimens harvested as control cases (normal carotid glomus whose immunohistochemical experiments were negative -data. not shown), from patients who died from myocardial infarction, and then processed with immunohistochemical techniques. All of the glomus were localized in the temporal bone and extended into the skull base. They were grouped according to Fisch classification. In this system (20) , C types (1, 2, 3) identify various degrees of involvement in the different portions of the carotid canal. Furthermore, the most recent version of the classification groups, both extradural (classes De1 and De2) and intradural (classes Di1 and Di2) include tumors with intracranial spread above or below 2 em in size, respectively.
• Experiments were performed in compliance with the Italian laws and guidelines concerning the patients 'informed consent. The ethical committee of the Hospital Policlinico Umberto I approved our study according to the European Community and Italian laws. The following molecules were investigated: nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), NT-3, NT-4 and the neurotrophin receptors tyrosine kinase A (TrKA), TrKB, TrKC, p75NTR and also MlB-l (Ki-67 antigen).
Immunohistochemical analysis
Small fragments of glomus tympanicum and normal carotid glomus (autoptic specimens) samples were washed in PBS, fixed in 10% formalin and embedded in paraffin according to a standard procedure. Serial 3urn thick sections were cut using a rotary microtome, mounted on gelatin-coated slides and processed for immunohistochemistry. To study the immunolocalization of neurotrophins and their own receptors, the following antibodies were used: a) rabbit anti-NGF polyclonal antibody (Santa Cruz, CA, USA) which displayed <1% cross-reactivity against recombinant human NT-3, NT-4 and BDNF; b) rabbit anti-TrKA polyclonal antibody (Santa Cruz, CA, USA) which recognized an epitope corresponding to amino acids 763 to 777, mapping adjacent to the carboxy-terminus of human TrKA p140; c) goat polyclonal antibody to human p75 NT receptor (Santa Cruz, CA, USA) which recognized the amino acid sequence mapping the carboxy-terminus of the p75 NT receptor precursor of human origin; d) rabbit anti-BDNF polyclonal antibody (Santa Cruz, CA, USA) which recognized the amino-terminal of mouse BDNF; e) rabbit anti-TrKB polyclonal antibody (Santa Cruz, CA, USA) which recognized an epitope corresponding to amino acids 794 to 808 of mouse TrKB p145; f) rabbit anti-NT-3 polyclonal antibody (Santa Cruz, CA, USA) which was raised against the amino-terminal of mouse NT-3; g) rabbit anti-TrKC antibody (Santa Cruz, CA, USA) which recognized an epitope corresponding to amino acids 798 to 812 of porcine TrKC p140; h) mouse monoclonal anti-human MIB-l (Ki-67 antigen; Dako Cytomation, Denmark). The MlB-l antibody recognizes native Ki-67 antigen and recombinant fragments of the Ki-67 molecule [Cattoretti et aI., 1992]. Incubation with primary antibodies was performed overnight at 4D C at a final concentration of2-5 ug/ml. Optimal antisera dilutions and incubation times were assessed in a series of preliminary experiments. After exposure to the primary antibodies, slides were rinsed twice in phosphate buffer and incubated for 90 min at room temperature with the appropriate secondary antibody conjugated to horseradish peroxidase (HRP) at a final dilution of 1:100. The secondary antibody-HRP linked against rabbit immunoglobulins was purchased from Boehringer (Mannheim GmbH , Mannheim, Germany), while secondary antibodies-HRP linked against mouse and goat immunoglobulins were from Sigma (Sigma Chemicals Co, St. Louis, MO, USA). After a further wash with phosphate buffer, slides were treated with 0.05% 3,3-diaminobenzidine (DAB) and 0.1% H202. Finally, sections were counterstained with Mayer's hematoxylin and observed by using a light microscope . To block endogenous peroxidase activity, slides were pretreated with 3% H202, whereas the non-specific binding of immunoglobulins was prevented by adding 3% fetal calf serum to the incubation medium . Negative control experiments were carried out: i) by omitting the primary antibody; ii) by substituting the primary antibody with an equivalent amount of non-specific immunoglobulins; iii) by pre-incubating the primary antibody with the specific blocking peptide (antigen/antibody = 5 according to supplier's instructions). The intensity of immune reaction was assessed microdensitometrically by an lAS 2000 image analyzer (Delta Sistemi, Rome, Italy) connected via a TV camera to the microscope . The system was calibrated taking the background obtained in sections exposed to non-immune serum as zero. Ten 100 J.1m 2 areas were delineated in each section by a measuring the diaphragm . Quantitative data of the intensity of the immune staining were analyzed statistically by analysis of variance (ANOVA) followed by Duncan's multiple range test as a post hoc test. The parameter examined by quantitative analysis was the distribution and the intensity of the immunoreaction. The registered values were transformed into a single number expressed as conventional unit, including the standard deviation. This number can be read on the display of the Quantimet 500 image analyzer.
RESULTS
Immunohistochemistry
The sections harvested from glomus tumors showed, in the neoplastic cells, a relevant immunoreactivity for NGF in the cytoplasmic compartment while it was moderate in the nuclear compartment ( Fig. IA) . TrKA immunoreactivity was significantly high in the cytoplasmic/nuclear compartments ofthe neoplastic cells, but moderate in the extracellular space ( Fig. IB) . Immunoreactivity for P75NTR was scarcely appreciable in the neoplastic cells and in the extracellular compartment ( Fig. IC) . BDNF showed a strong expression in the extracellular compartment but was weak in the neoplastic cells ( Fig. 2A) . TrKB was highly expressed in the cytoplasmic compartment of the neoplastic cells, while moderate in the nuclear compartment ( Fig. 2B ). MIB-I was appreciable in the nuclear compartment of the neoplastic cells but totally absent in the extracellular space (Fig.  2C ). NT-3 was only appreciable in the cytoplasmic compartment and absent in the extracellular space (Fig. 3A) . NT-4 showed a strong expression in the cytoplasmic compartment of the neoplastic cells and moderate in the nuclear compartment ( Fig. 3B ). Immunoreactivity for TrKC was strongly present in the cytoplasmic compartment of the neoplastic cells and moderate in the extracellular space ( Fig. 3C) . Table I depicts the comparison between the rate of cytoplasmatic neurotrophins and the jugulotympanic paragangliomas.All ofthe patients showed strong or very strong immunoreactivity.
In Table II the recurrent and non-recurrent paragangliomas are summarized. It should be emphasized that 2 of the 3 recurrences had a very strong immunoreactivity and that none of the non-recurrent patients had this wider distribution of the neutrophins. This leads to hypothesize the involvement of these substances in the cell proliferation of glomus tumors.
DISCUSSION
It is well known that NGF has an inflammatory role and its increase is directly related to inflammation and disease of the immune system (16) (17) , probably due to the direct action of NGF on mast cells and sensory neurones, as proposed by Woolf et al. (21) . NTs are neurotrophic signalling polypeptides which include NGF, BDNF, NT-3, NT-4/5 and NT-6, the latter apparently being specific to fish (13) (14) . The biological effects ofNTs are mediated by the binding with two families of membrane receptors, the high affinity TrK and low affinity p75NT receptor (13) (14) .
The TrK family includes TrKA, TrKB and TrKC receptors, whereas p75NT receptor belongs to the trans-membrane molecules serving as receptors for tumor necrosis factor and cytokines (14) . TrKA is specifically activated by NGF, whereas TrKB and TrKC are primarily receptors for BDNF and NT-3 respectively (13) . The physiological role of NTs in the development, maintenance and regeneration of the sympathetic and sensory nervous system has been well established (22) (23) (24) and NGF mainly induces differentiation and decreases growth rate in a variety of neoplastic cells from neurogenic and non-neurogenic origin (25) . There is increasing evidence that NTs may act together with a paracrine mechanism in the regulation of the functional activity of neuronal and non-neuronal structures. We decided to investigate the expression of neurotrophins and their relative receptors, in samples of intradural jugulo-tympanic tumors, according to the observations of Yamamoto et al. (12) , who first described the immunohistochemical profile of expression of the NTs, in order to find a correlation and a direct involvement of these growth factors in the development ofthis type ofneoplastic malignancy or in the development of recurrence. Yamamoto et al. (12) found a generally positive reaction, in the samples of glomus tumors, for the neurotrophins and their relative receptors, but we more specifically defined the sub-cellular localization and expression of these neurotrophic factors. The sections harvested from glomus tumors showed, in the neoplastic cells, a relevant immunoreactivity for NGF in the cytoplasmic compartment while it was moderate in the nuclear compartment, suggesting the direct role of this neurotrophin in increasing the proliferation rate of the neoplastic cells. NGF high-affinity receptor, TrKA, immunoreactivity was significantly high in the cytoplasmic/nuclear compartment of the neoplastic cells but moderate in the extracellular compartment. BDNF showed a strong expression in the extracellular compartment but was weak in the neoplastic cells, suggesting an involvement of this factor in the spreading out ofthe "neoplastic capsule", supported by the neo-angiogenetic process. BDNF high-affinity receptor, TrKB, was highly expressed in the cytoplasmic compartment while moderate in the nuclear compartment of the neoplastic cells. NT-3 was only appreciable in the cytoplasmic space and absent in the extracellular compartment . NT-4 showed a strong expression in the cytoplasmic compartment of the neoplastic cells and moderate in the nuclear compartment. Immunoreactivity for TrKC was strongly present in the cytoplasmic compartment and moderate in the extracellular space. To sum up, we observed a generally relevant positive immunoreaction for NGF -TrKA -NT4 -TrKC in the cytoplasmic compartment, suggesting a direct role of these molecules in increasing the cell proliferation rate in the neoplastic tissue. These findings were compared with the clinical evolution of these patients. Surprisingly, 2 out of the 3 recurrences showed a very strong immunoreactivity with neurotrophins overexpressed in intradural glomus. Although the small number of patients does not allow a reliable statistical analysis, impeding definitive conclusions to be made, our findings show a possible trend towards significance which requires a more powerful study to evaluate further.
On the other hand, we found a strong expression for BDNF in the extracellular space, suggesting that this factor directly influences the spreading out of the neoplastic cells, related to an increase in tumor size, also due to a high vascularization network. Neurotrophins and their own receptors can finally be used all together as a panel of possible diagnostic factors, to follow the histological transformation and development of jugulotympanic tumours, although discrimination between the benign and malignant forms remains unclear.
On the contrary, MIB-I (anti Ki-67) was appreciable in the nuclear compartment of the neoplastic cells but weak in the cytoplasmic compartment, and totally absent in the extracellular space, contrasting with the high proliferation activity usually present in the malignant cells. Actually, there is not a clear current ofthought regarding the efficacy and diagnostic significance ofthe MIB-I index in the glomus tumors. Karamitopoulou et al. (26) showed that, while malignant central nervous system tumors always exhibited high Ki-67 labeling index values, and benign central nervous system tumors generally displayed lower values, increased immunoreactivity for Ki-67 epitopes could be noted in a number of meningiomas, astrocytomas, ependymomas, oligodendrogliomas, and paragangliomas, contrasting with their benign histological features. On the other hand, previous studies (27) established that MIB-I has a correlation with tumor size and the cell differentiation patterns of these tumors. In fact, more highly differentiated glomus tumors are more similar to normal tissue and, consequently, they contain more cytoplasmic granules and react more intensely to the Ki-67 antigen: undifferentiated tumors have less reactivity to this marker. Regarding tumor size, neoplasms < 5 em showed a low reactivity to MIB-I, while neoplasms > 5 em had a more increased level of this marker. Therefore, malignant forms ofthe glomus tumors (which tend to present a cellular undifferentiation) cannot be clearly identified using MIB-I as a significant diagnostic and prognostic marker, which, on the contrary, results highly expressed in the differentiated benign form of the neoplasms mentioned. Concerning the subcellular localization of neurotrophins in human cells we may agree with Kryl et at. (28) who affirm that Trk receptors are uniformly distributed in both axonal and dendritic compartments and that local neurotrophin responses are controlled by other mechanisms. Moreover, according to Lessman et at. (29) , it is possible to confirm that NTs are expected to be expressed in the cell soma of non-neuronal cells and in the soma and dendrites of innervated neurons upon which the innervating axons terminate. Following secretion ofthese target-derived NTs, they bind to axonal Trk and p75 receptors, thus becoming endocytosed and transported retrogradely in the axon to the cell soma where they can activate survival promoting cellular signaling cascades. In extension ofthis classical retrograde route destined to exert the long-lasting effects ofNTs, which are, for example, mediated by new gene transcription, recent evidence suggests additional anterograde targeting in the axon towards synaptic terminals.
In conclusion, as little is known in literature about these rare cases of neoplastic malignancies, we can only affirm that neurotrophins and their own receptors, may be considered as possible diagnostic markers to monitor the development and the histopathological characterization of jugulotympanic tumors.
